Blog Where innovation, insight & ideas combine. Contact Us Ask The Experts Home Blog Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics® Read Now Categories View all categories14C Radiolabeling505(b)(2)AlnwickBioanalysisBiopharmaceuticsBlogCandidate DevelopmentCandidate SelectionCareersClinical PharmacologyClinical Trial ManufacturingClinical Trial SuppliesColleague StoriesCommercial ManufacturingCorporate UpdatesCRDMOData SciencesDenise SuttonDennis HendersonDr. Adam Robinson-MillerDr. Andrew LewisDr. Aruna RailkarDr. Asma PatelDr. Gareth JenkinsDr. Helen BakerDr. Peter ScholesDr. Richard Castledine Dr. Stuart MairDr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementThierry Van NieuwenhoveDrug SubstanceIntegrated ProgramsSustainabilityTranslational Pharmaceutics Publish Date View all time20252024202320222021202020192018 Fulltext search 71 - 75 of 121 results Scientific Innovation, Modified Release, Translational PharmaceuticsDrug Development Innovation: 3D printing of pharmaceutical dosage forms – has the time come?Scientific Innovation, Modified Release, Translational PharmaceuticsDrug Development Innovation: 3D printing of pharmaceutical dosage forms – has the time come?Learn more Careers, ReadingColleague Stories: Faria SenjotiCareers, ReadingColleague Stories: Faria SenjotiLearn more Formulation Development, Early Development, Drug Product Optimization, Late Development, Dr. Andrew LewisIntegrated Development Strategies, Part 2: Reformulating for clinical and commercial successFormulation Development, Early Development, Drug Product Optimization, Late Development, Dr. Andrew LewisIntegrated Development Strategies, Part 2: Reformulating for clinical and commercial successLearn more Candidate Development, Drug Substance to Drug ProductHow to streamline the development of your molecule from candidate selection to first-in-human clinical testingCandidate Development, Drug Substance to Drug ProductHow to streamline the development of your molecule from candidate selection to first-in-human clinical testingLearn more Modeling and Simulation, Data SciencesHow to leverage Modeling and Simulation in the candidate development stage to help ensure clinical successBy: Dr. Alison WilbyModeling and Simulation, Data SciencesHow to leverage Modeling and Simulation in the candidate development stage to help ensure clinical successBy: Dr. Alison WilbyLearn more Pagination First page « First Previous page ‹ Previous … Page 13 Page 14 Page 15 Page 16 Page 17 … Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Get in touch Humanity can't afford to wait, so neither can we. Let's talk
